Codes / ICD10CM / T65.5X2S

T65.5X2S Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Nitroglycerin and Other Nitric Acids and Esters, Intentional Self-Harm, Sequela

Summary

This condition describes residual or late effects following intentional self-harm involving nitroglycerin or other nitric acids and esters. Sequela refers to complications or conditions that persist after the acute toxic episode, potentially affecting cardiovascular, neurological, or other systems. The effects may result from prior exposure to these substances, with symptoms or impairments continuing beyond the active phase of poisoning.

Causes

The sequela arises from intentional self-harm involving nitroglycerin or related nitric acids and esters, where the initial toxic exposure led to lasting health consequences. The original exposure typically occurred through ingestion, inhalation, or dermal contact, with the subsequent effects persisting due to tissue damage, organ dysfunction, or unresolved metabolic disturbances from the acute event.

Risk Factors

  • History of intentional self-harm with nitroglycerin or nitric acid esters.
  • Prior severe toxicity from these substances, increasing risk of permanent damage.
  • Delayed or inadequate treatment during the acute phase of poisoning.
  • Pre-existing conditions that may exacerbate long-term effects (e.g., cardiovascular disease).

Symptoms

  • Persistent hypotension or tachycardia.
  • Chronic headaches or neurological deficits (e.g., cognitive impairment, seizures).
  • Gastrointestinal issues (e.g., recurrent nausea, abdominal pain).
  • Skin changes or scarring from dermal exposure.
  • Respiratory or metabolic complications (e.g., chronic dyspnea, methemoglobinemia).

Diagnosis

Diagnosis is based on clinical history of intentional self-harm with nitroglycerin or nitric acid esters, followed by evidence of persistent symptoms or impairments. Documentation must link current findings to the prior toxic exposure, often requiring imaging, lab tests, or specialist evaluations to confirm residual effects. The sequela code is assigned when the condition is present after the acute phase of poisoning.

Treatment Options

Treatment focuses on managing residual symptoms and preventing further complications. This may include ongoing cardiovascular monitoring, neurological rehabilitation, or supportive care for chronic organ dysfunction. Interventions are tailored to the specific sequelae, such as medication for persistent hypotension or therapy for cognitive deficits.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial toxicity and the extent of residual damage. Some sequelae may improve with time, while others may be permanent. Regular follow-up is essential to monitor for worsening symptoms, adjust treatments, and address psychosocial needs related to the prior self-harm event.

Complications

  • Chronic cardiovascular instability (e.g., refractory hypotension).
  • Neurological damage (e.g., persistent seizures, cognitive decline).
  • Gastrointestinal or respiratory impairment.
  • Psychological sequelae (e.g., depression, anxiety) related to the self-harm incident.

Lifestyle & Prevention

  • Avoid re-exposure to nitroglycerin or nitric acid esters.
  • Follow-up with mental health professionals to address underlying self-harm risks.
  • Adhere to prescribed treatments for residual symptoms.
  • Maintain regular medical monitoring to detect new or worsening complications.

When to Seek Professional Help

Seek immediate medical attention if new or worsening symptoms occur, such as severe dizziness, chest pain, difficulty breathing, or signs of organ dysfunction. Ongoing psychiatric support is recommended to address the underlying intent of the prior self-harm.

Tips for Medical Coders

Use this code for sequelae resulting from intentional self-harm with nitroglycerin or nitric acid esters. Document the link between the prior toxic exposure and current residual effects, including clinical findings and timeline. Ensure the sequela is distinct from active toxicity and that the intent (intentional self-harm) is clearly recorded.

Book a walkthrough

T65.5X2S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.